Rilotumumab (AMG 102) is a monoclonal antibody targeting hepatocyte growth factor (HGF), designed to inhibit HGF/MET signaling pathways. This antibody demonstrates potent anti-tumor activity and is primarily utilized in the study of castration-resistant prostate cancer (CRPC) and other solid tumors. Rilotumumab offers a strategic tool for researchers investigating the role of HGF/MET interactions in cancer progression and therapeutic resistance.
Rilotumumab (AMG 102) is a monoclonal antibody targeting hepatocyte growth factor (HGF), designed to inhibit HGF/MET signaling pathways. This antibody demonstrates potent anti-tumor activity and is primarily utilized in the study of castration-resistant prostate cancer (CRPC) and other solid tumors. Rilotumumab offers a strategic tool for researchers investigating the role of HGF/MET interactions in cancer progression and therapeutic resistance.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
